SEC Form 4 · accession 0001950129-26-000006
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hilda Frederique Scharen-Guivel
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 4, 2026 · 4:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 4, 2026 | S | 1,766 | $95.00 | D | 6,832 | D | |
| Common StockF1,F2 | Jun 4, 2026 | S | 1,234 | $95.00 | D | 5,598 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed at $95.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The shares reported as beneficially owned following the reported transaction consist of shares acquired upon the vesting and settlement of restricted stock units granted in connection with the reporting person's service as a director. Such shares were acquired in multiple vesting transactions occurring on various dates.